AVNS icon

Avanos Medical

12.71 USD
-0.39
2.98%
At close May 13, 4:00 PM EDT
After hours
13.11
+0.40
3.15%
1 day
-2.98%
5 days
-1.01%
1 month
2.42%
3 months
-23.57%
6 months
-34.79%
Year to date
-19.71%
1 year
-36.07%
5 years
-50.70%
10 years
-77.78%
 

About: Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

Employees: 2,227

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

23% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 62

0.89% more ownership

Funds ownership: 92.96% [Q3] → 93.85% (+0.89%) [Q4]

2% less first-time investments, than exits

New positions opened: 44 | Existing positions closed: 45

2% less funds holding

Funds holding: 258 [Q3] → 253 (-5) [Q4]

12% less call options, than puts

Call options by funds: $88K | Put options by funds: $100K

33% less capital invested

Capital invested by funds: $1.03B [Q3] → $687M (-$339M) [Q4]

100% less funds holding in top 10

Funds holding in top 10: 1 [Q3] → 0 (-1) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for AVNS.

Financial journalist opinion

Based on 7 articles about AVNS published over the past 30 days

Neutral
Zacks Investment Research
20 hours ago
Avanos Medical (AVNS) International Revenue in Focus: Trends and Expectations
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Avanos Medical (AVNS) International Revenue in Focus: Trends and Expectations
Negative
Zacks Investment Research
4 days ago
New Strong Sell Stocks for May 9th
AVNS, BCC and AMPY have been added to the Zacks Rank #5 (Strong Sell) List on May 9, 2025.
New Strong Sell Stocks for May 9th
Positive
Zacks Investment Research
6 days ago
AVNS Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
Strength in Avanos' SNS segment drives its first-quarter 2025 performance despite global macroeconomic challenges.
AVNS Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
Neutral
Seeking Alpha
1 week ago
Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript
Avanos Medical, Inc. (NYSE:AVNS ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy and Corporate Development Dave Pacitti - Chief Executive Officer Jason Pickett - Interim Chief Financial Officer and Treasurer Conference Call Participants Rick Wise - Stifel Daniel Stauder - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos First Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Tuesday, May 6, 2025.
Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript
Positive
Zacks Investment Research
1 week ago
Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates
Avanos Medical (AVNS) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.22 per share a year ago.
Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates
Neutral
PRNewsWire
1 week ago
Avanos Medical, Inc. Announces First Quarter 2025 Results
ALPHARETTA, Ga. , May 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2025 financial results.
Avanos Medical, Inc. Announces First Quarter 2025 Results
Neutral
PRNewsWire
2 weeks ago
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results
ALPHARETTA, Ga. , April 28, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2025 on Tuesday, May 6 at 9 a.m.
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results
Positive
Zacks Investment Research
1 month ago
AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK
Avanos takes direct control of MIC-KEY sales in the UK, enhancing market presence, customer engagement and service efficiency, starting July 2025.
AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK
Neutral
PRNewsWire
1 month ago
Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025
ZAVENTEM, Belgium , April 2, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) a global medical technology company, today announced that it will take direct responsibility for the sales and distribution of its MIC-KEY enteral feeding products in the United Kingdom, effective 25 July 2025. This strategic move reflects Avanos' commitment to prioritizing customer needs, enhancing product availability into the future, and providing a seamless experience for healthcare providers and patients.
Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025
Negative
Zacks Investment Research
1 month ago
New Strong Sell Stocks for March 24th
AVNS, AIRS and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2025.
New Strong Sell Stocks for March 24th
Charts implemented using Lightweight Charts™